Sigma Peptides CJC 1295 + Ipamorelin 20mg

This preparation combines CJC-1295 (a GHRH analogue) with Ipamorelin (a selective ghrelin receptor agonist) in one vial. Engaging two distinct pathways — GHRH and ghrelin — is among the most frequently used designs in research on synergistic growth hormone secretion. The 20mg size is available to match the volume your research requires.

Every batch is tested by an independent laboratory: purity ≥99.4%, identity confirmed by LC-MS, and endotoxin below 0.5 EU/mg.

Store the lyophilised vial at 2–8 °C, protected from light. Once reconstituted, keep at 2–8 °C and use within 3–4 weeks. Shipped throughout Indonesia in protective packaging.

For in-vitro and laboratory research use only.